 | • レポートコード：MRC2-11QY03290 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオ治療用糖タンパク質のグローバル市場について調査・分析したレポートです。種類別（抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤）市場規模、用途別（腫瘍学・血液学、糖尿病、心臓病学、炎症性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオ治療用糖タンパク質の競争状況、市場シェア ・世界のバイオ治療用糖タンパク質市場：種類別市場規模 2015年-2020年（抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤） ・世界のバイオ治療用糖タンパク質市場：種類別市場規模予測 2021年-2026年（抗血清、サイトカイン、凝固因子、ホルモン、酵素、酵素阻害剤） ・世界のバイオ治療用糖タンパク質市場：用途別市場規模 2015年-2020年（腫瘍学・血液学、糖尿病、心臓病学、炎症性疾患、その他） ・世界のバイオ治療用糖タンパク質市場：用途別市場規模予測 2021年-2026年（腫瘍学・血液学、糖尿病、心臓病学、炎症性疾患、その他） ・北米のバイオ治療用糖タンパク質市場分析：米国、カナダ ・ヨーロッパのバイオ治療用糖タンパク質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオ治療用糖タンパク質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオ治療用糖タンパク質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオ治療用糖タンパク質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Genentech、Hoffmann-La Roche、Genzyme Corp、Abbott Laboratories、Amgen、Biogen、Merck、GlaxoSmithKline、Novartis Pharmaceuticals Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either α and β linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan’s linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.
The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.
Market Analysis and Insights: Global Bio-Therapeutic Glycoproteins Market
The global Bio-Therapeutic Glycoproteins market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bio-Therapeutic Glycoproteins Scope and Market Size
Bio-Therapeutic Glycoproteins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio-Therapeutic Glycoproteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bio-Therapeutic Glycoproteins market is segmented into
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors
Segment by Application, the Bio-Therapeutic Glycoproteins market is segmented into
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others
Regional and Country-level Analysis
The Bio-Therapeutic Glycoproteins market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bio-Therapeutic Glycoproteins market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bio-Therapeutic Glycoproteins Market Share Analysis
Bio-Therapeutic Glycoproteins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio-Therapeutic Glycoproteins business, the date to enter into the Bio-Therapeutic Glycoproteins market, Bio-Therapeutic Glycoproteins product introduction, recent developments, etc.
The major vendors covered:
Genentech
Hoffmann-La Roche
Genzyme Corp
Abbott Laboratories
Amgen
Biogen
Merck
GlaxoSmithKline
Novartis Pharmaceuticals Corp
1 Study Coverage
1.1 Bio-Therapeutic Glycoproteins Product Introduction
1.2 Market Segments
1.3 Key Bio-Therapeutic Glycoproteins Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Type
1.4.2 Antisera
1.4.3 Cytokines
1.4.4 Clotting Factors
1.4.5 Hormones
1.4.6 Enzymes
1.4.7 Enzyme Inhibitors
1.5 Market by Application
1.5.1 Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Application
1.5.2 Oncology and Haematology
1.5.3 Diabetes
1.5.4 Cardiology
1.5.5 Inflammatory Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bio-Therapeutic Glycoproteins Market Size, Estimates and Forecasts
2.1.1 Global Bio-Therapeutic Glycoproteins Revenue 2015-2026
2.1.2 Global Bio-Therapeutic Glycoproteins Sales 2015-2026
2.2 Global Bio-Therapeutic Glycoproteins, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bio-Therapeutic Glycoproteins Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio-Therapeutic Glycoproteins Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio-Therapeutic Glycoproteins Competitor Landscape by Players
3.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers
3.1.1 Bio-Therapeutic Glycoproteins Sales by Manufacturers (2015-2020)
3.1.2 Bio-Therapeutic Glycoproteins Sales Market Share by Manufacturers (2015-2020)
3.2 Bio-Therapeutic Glycoproteins Revenue by Manufacturers
3.2.1 Bio-Therapeutic Glycoproteins Revenue by Manufacturers (2015-2020)
3.2.2 Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio-Therapeutic Glycoproteins Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio-Therapeutic Glycoproteins Revenue in 2019
3.2.5 Global Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio-Therapeutic Glycoproteins Price by Manufacturers
3.4 Bio-Therapeutic Glycoproteins Manufacturing Base Distribution, Product Types
3.4.1 Bio-Therapeutic Glycoproteins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio-Therapeutic Glycoproteins Product Type
3.4.3 Date of International Manufacturers Enter into Bio-Therapeutic Glycoproteins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bio-Therapeutic Glycoproteins Market Size by Type (2015-2020)
4.1.1 Global Bio-Therapeutic Glycoproteins Sales by Type (2015-2020)
4.1.2 Global Bio-Therapeutic Glycoproteins Revenue by Type (2015-2020)
4.1.3 Bio-Therapeutic Glycoproteins Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio-Therapeutic Glycoproteins Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Type (2021-2026)
4.2.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Type (2021-2026)
4.2.3 Bio-Therapeutic Glycoproteins Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio-Therapeutic Glycoproteins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bio-Therapeutic Glycoproteins Market Size by Application (2015-2020)
5.1.1 Global Bio-Therapeutic Glycoproteins Sales by Application (2015-2020)
5.1.2 Global Bio-Therapeutic Glycoproteins Revenue by Application (2015-2020)
5.1.3 Bio-Therapeutic Glycoproteins Price by Application (2015-2020)
5.2 Bio-Therapeutic Glycoproteins Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Application (2021-2026)
5.2.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio-Therapeutic Glycoproteins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio-Therapeutic Glycoproteins by Country
6.1.1 North America Bio-Therapeutic Glycoproteins Sales by Country
6.1.2 North America Bio-Therapeutic Glycoproteins Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio-Therapeutic Glycoproteins Market Facts & Figures by Type
6.3 North America Bio-Therapeutic Glycoproteins Market Facts & Figures by Application
7 Europe
7.1 Europe Bio-Therapeutic Glycoproteins by Country
7.1.1 Europe Bio-Therapeutic Glycoproteins Sales by Country
7.1.2 Europe Bio-Therapeutic Glycoproteins Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio-Therapeutic Glycoproteins Market Facts & Figures by Type
7.3 Europe Bio-Therapeutic Glycoproteins Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio-Therapeutic Glycoproteins by Region
8.1.1 Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region
8.1.2 Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio-Therapeutic Glycoproteins Market Facts & Figures by Type
8.3 Asia Pacific Bio-Therapeutic Glycoproteins Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio-Therapeutic Glycoproteins by Country
9.1.1 Latin America Bio-Therapeutic Glycoproteins Sales by Country
9.1.2 Latin America Bio-Therapeutic Glycoproteins Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio-Therapeutic Glycoproteins Market Facts & Figures by Type
9.3 Central & South America Bio-Therapeutic Glycoproteins Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio-Therapeutic Glycoproteins by Country
10.1.1 Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country
10.1.2 Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bio-Therapeutic Glycoproteins Market Facts & Figures by Type
10.3 Middle East and Africa Bio-Therapeutic Glycoproteins Market Facts & Figures by Application
11 Company Profiles
11.1 Genentech
11.1.1 Genentech Corporation Information
11.1.2 Genentech Description and Business Overview
11.1.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Bio-Therapeutic Glycoproteins Products Offered
11.1.5 Genentech Related Developments
11.2 Hoffmann-La Roche
11.2.1 Hoffmann-La Roche Corporation Information
11.2.2 Hoffmann-La Roche Description and Business Overview
11.2.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Products Offered
11.2.5 Hoffmann-La Roche Related Developments
11.3 Genzyme Corp
11.3.1 Genzyme Corp Corporation Information
11.3.2 Genzyme Corp Description and Business Overview
11.3.3 Genzyme Corp Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Genzyme Corp Bio-Therapeutic Glycoproteins Products Offered
11.3.5 Genzyme Corp Related Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Description and Business Overview
11.4.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Laboratories Bio-Therapeutic Glycoproteins Products Offered
11.4.5 Abbott Laboratories Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Bio-Therapeutic Glycoproteins Products Offered
11.5.5 Amgen Related Developments
11.6 Biogen
11.6.1 Biogen Corporation Information
11.6.2 Biogen Description and Business Overview
11.6.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biogen Bio-Therapeutic Glycoproteins Products Offered
11.6.5 Biogen Related Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Description and Business Overview
11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck Bio-Therapeutic Glycoproteins Products Offered
11.7.5 Merck Related Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description and Business Overview
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline Bio-Therapeutic Glycoproteins Products Offered
11.8.5 GlaxoSmithKline Related Developments
11.9 Novartis Pharmaceuticals Corp
11.9.1 Novartis Pharmaceuticals Corp Corporation Information
11.9.2 Novartis Pharmaceuticals Corp Description and Business Overview
11.9.3 Novartis Pharmaceuticals Corp Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Products Offered
11.9.5 Novartis Pharmaceuticals Corp Related Developments
11.1 Genentech
11.1.1 Genentech Corporation Information
11.1.2 Genentech Description and Business Overview
11.1.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Bio-Therapeutic Glycoproteins Products Offered
11.1.5 Genentech Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio-Therapeutic Glycoproteins Market Estimates and Projections by Region
12.1.1 Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions 2021-2026
12.1.2 Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions 2021-2026
12.2 North America Bio-Therapeutic Glycoproteins Market Size Forecast (2021-2026)
12.2.1 North America: Bio-Therapeutic Glycoproteins Sales Forecast (2021-2026)
12.2.2 North America: Bio-Therapeutic Glycoproteins Revenue Forecast (2021-2026)
12.2.3 North America: Bio-Therapeutic Glycoproteins Market Size Forecast by Country (2021-2026)
12.3 Europe Bio-Therapeutic Glycoproteins Market Size Forecast (2021-2026)
12.3.1 Europe: Bio-Therapeutic Glycoproteins Sales Forecast (2021-2026)
12.3.2 Europe: Bio-Therapeutic Glycoproteins Revenue Forecast (2021-2026)
12.3.3 Europe: Bio-Therapeutic Glycoproteins Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio-Therapeutic Glycoproteins Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio-Therapeutic Glycoproteins Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio-Therapeutic Glycoproteins Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio-Therapeutic Glycoproteins Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio-Therapeutic Glycoproteins Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio-Therapeutic Glycoproteins Sales Forecast (2021-2026)
12.5.2 Latin America: Bio-Therapeutic Glycoproteins Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio-Therapeutic Glycoproteins Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio-Therapeutic Glycoproteins Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio-Therapeutic Glycoproteins Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio-Therapeutic Glycoproteins Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio-Therapeutic Glycoproteins Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bio-Therapeutic Glycoproteins Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio-Therapeutic Glycoproteins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bio-Therapeutic Glycoproteins Market Segments
Table 2. Ranking of Global Top Bio-Therapeutic Glycoproteins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antisera
Table 5. Major Manufacturers of Cytokines
Table 6. Major Manufacturers of Clotting Factors
Table 7. Major Manufacturers of Hormones
Table 8. Major Manufacturers of Enzymes
Table 9. Major Manufacturers of Enzyme Inhibitors
Table 10. Global Bio-Therapeutic Glycoproteins Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Bio-Therapeutic Glycoproteins Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Bio-Therapeutic Glycoproteins Sales by Regions 2015-2020 (K MT)
Table 13. Global Bio-Therapeutic Glycoproteins Sales Market Share by Regions (2015-2020)
Table 14. Global Bio-Therapeutic Glycoproteins Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Bio-Therapeutic Glycoproteins Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Bio-Therapeutic Glycoproteins Sales Share by Manufacturers (2015-2020)
Table 17. Global Bio-Therapeutic Glycoproteins Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Bio-Therapeutic Glycoproteins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-Therapeutic Glycoproteins as of 2019)
Table 19. Bio-Therapeutic Glycoproteins Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Bio-Therapeutic Glycoproteins Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Bio-Therapeutic Glycoproteins Price (2015-2020) (USD/MT)
Table 22. Bio-Therapeutic Glycoproteins Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Bio-Therapeutic Glycoproteins Product Type
Table 24. Date of International Manufacturers Enter into Bio-Therapeutic Glycoproteins Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 27. Global Bio-Therapeutic Glycoproteins Sales Share by Type (2015-2020)
Table 28. Global Bio-Therapeutic Glycoproteins Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Bio-Therapeutic Glycoproteins Revenue Share by Type (2015-2020)
Table 30. Bio-Therapeutic Glycoproteins Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 32. Global Bio-Therapeutic Glycoproteins Sales Share by Application (2015-2020)
Table 33. North America Bio-Therapeutic Glycoproteins Sales by Country (2015-2020) (K MT)
Table 34. North America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2015-2020)
Table 35. North America Bio-Therapeutic Glycoproteins Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2015-2020)
Table 37. North America Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 38. North America Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Table 39. North America Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 40. North America Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Table 41. Europe Bio-Therapeutic Glycoproteins Sales by Country (2015-2020) (K MT)
Table 42. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Country (2015-2020)
Table 43. Europe Bio-Therapeutic Glycoproteins Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2015-2020)
Table 45. Europe Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 46. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Table 47. Europe Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 48. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Region (2015-2020) (K MT)
Table 50. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Bio-Therapeutic Glycoproteins Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 54. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 56. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Table 57. Latin America Bio-Therapeutic Glycoproteins Sales by Country (2015-2020) (K MT)
Table 58. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Bio-Therapeutic Glycoproteins Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2015-2020)
Table 61. Latin America Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 62. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Table 63. Latin America Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 64. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Country (2015-2020) (K MT)
Table 66. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Type (2015-2020) (K MT)
Table 70. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Bio-Therapeutic Glycoproteins Sales by Application (2015-2020) (K MT)
Table 72. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Table 73. Genentech Corporation Information
Table 74. Genentech Description and Major Businesses
Table 75. Genentech Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Genentech Product
Table 77. Genentech Recent Development
Table 78. Hoffmann-La Roche Corporation Information
Table 79. Hoffmann-La Roche Description and Major Businesses
Table 80. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Hoffmann-La Roche Product
Table 82. Hoffmann-La Roche Recent Development
Table 83. Genzyme Corp Corporation Information
Table 84. Genzyme Corp Description and Major Businesses
Table 85. Genzyme Corp Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Genzyme Corp Product
Table 87. Genzyme Corp Recent Development
Table 88. Abbott Laboratories Corporation Information
Table 89. Abbott Laboratories Description and Major Businesses
Table 90. Abbott Laboratories Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Abbott Laboratories Product
Table 92. Abbott Laboratories Recent Development
Table 93. Amgen Corporation Information
Table 94. Amgen Description and Major Businesses
Table 95. Amgen Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Amgen Product
Table 97. Amgen Recent Development
Table 98. Biogen Corporation Information
Table 99. Biogen Description and Major Businesses
Table 100. Biogen Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Biogen Product
Table 102. Biogen Recent Development
Table 103. Merck Corporation Information
Table 104. Merck Description and Major Businesses
Table 105. Merck Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Merck Product
Table 107. Merck Recent Development
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Recent Development
Table 113. Novartis Pharmaceuticals Corp Corporation Information
Table 114. Novartis Pharmaceuticals Corp Description and Major Businesses
Table 115. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Novartis Pharmaceuticals Corp Product
Table 117. Novartis Pharmaceuticals Corp Recent Development
Table 118. Global Bio-Therapeutic Glycoproteins Sales Forecast by Regions (2021-2026) (K MT)
Table 119. Global Bio-Therapeutic Glycoproteins Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global Bio-Therapeutic Glycoproteins Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global Bio-Therapeutic Glycoproteins Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: Bio-Therapeutic Glycoproteins Sales Forecast by Country (2021-2026) (K MT)
Table 123. North America: Bio-Therapeutic Glycoproteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: Bio-Therapeutic Glycoproteins Sales Forecast by Country (2021-2026) (K MT)
Table 125. Europe: Bio-Therapeutic Glycoproteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: Bio-Therapeutic Glycoproteins Sales Forecast by Region (2021-2026) (K MT)
Table 127. Asia Pacific: Bio-Therapeutic Glycoproteins Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: Bio-Therapeutic Glycoproteins Sales Forecast by Country (2021-2026) (K MT)
Table 129. Latin America: Bio-Therapeutic Glycoproteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: Bio-Therapeutic Glycoproteins Sales Forecast by Country (2021-2026) (K MT)
Table 131. Middle East and Africa: Bio-Therapeutic Glycoproteins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Bio-Therapeutic Glycoproteins Players
Table 136. Bio-Therapeutic Glycoproteins Customers List
Table 137. Bio-Therapeutic Glycoproteins Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-Therapeutic Glycoproteins Product Picture
Figure 2. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2020 & 2026
Figure 3. Antisera Product Picture
Figure 4. Cytokines Product Picture
Figure 5. Clotting Factors Product Picture
Figure 6. Hormones Product Picture
Figure 7. Enzymes Product Picture
Figure 8. Enzyme Inhibitors Product Picture
Figure 9. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2020 & 2026
Figure 10. Oncology and Haematology
Figure 11. Diabetes
Figure 12. Cardiology
Figure 13. Inflammatory Diseases
Figure 14. Others
Figure 15. Bio-Therapeutic Glycoproteins Report Years Considered
Figure 16. Global Bio-Therapeutic Glycoproteins Market Size 2015-2026 (US$ Million)
Figure 17. Global Bio-Therapeutic Glycoproteins Sales 2015-2026 (K MT)
Figure 18. Global Bio-Therapeutic Glycoproteins Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region (2015-2020)
Figure 20. Global Bio-Therapeutic Glycoproteins Sales Market Share by Region in 2019
Figure 21. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region (2015-2020)
Figure 22. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Region in 2019
Figure 23. Global Bio-Therapeutic Glycoproteins Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Bio-Therapeutic Glycoproteins Revenue in 2019
Figure 25. Bio-Therapeutic Glycoproteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type (2015-2020)
Figure 27. Global Bio-Therapeutic Glycoproteins Sales Market Share by Type in 2019
Figure 28. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type (2015-2020)
Figure 29. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Type in 2019
Figure 30. Global Bio-Therapeutic Glycoproteins Market Share by Price Range (2015-2020)
Figure 31. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application (2015-2020)
Figure 32. Global Bio-Therapeutic Glycoproteins Sales Market Share by Application in 2019
Figure 33. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application (2015-2020)
Figure 34. Global Bio-Therapeutic Glycoproteins Revenue Market Share by Application in 2019
Figure 35. North America Bio-Therapeutic Glycoproteins Sales Growth Rate 2015-2020 (K MT)
Figure 36. North America Bio-Therapeutic Glycoproteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Bio-Therapeutic Glycoproteins Sales Market Share by Country in 2019
Figure 38. North America Bio-Therapeutic Glycoproteins Revenue Market Share by Country in 2019
Figure 39. U.S. Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.S. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 42. Canada Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Figure 44. North America Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure 45. Europe Bio-Therapeutic Glycoproteins Sales Growth Rate 2015-2020 (K MT)
Figure 46. Europe Bio-Therapeutic Glycoproteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Bio-Therapeutic Glycoproteins Sales Market Share by Country in 2019
Figure 48. Europe Bio-Therapeutic Glycoproteins Revenue Market Share by Country in 2019
Figure 49. Germany Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 50. Germany Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 52. France Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 54. U.K. Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 56. Italy Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 58. Russia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Figure 60. Europe Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure 61. Asia Pacific Bio-Therapeutic Glycoproteins Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Bio-Therapeutic Glycoproteins Sales Market Share by Region in 2019
Figure 64. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Market Share by Region in 2019
Figure 65. China Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Figure 88. Asia Pacific Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure 89. Latin America Bio-Therapeutic Glycoproteins Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Bio-Therapeutic Glycoproteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Bio-Therapeutic Glycoproteins Sales Market Share by Country in 2019
Figure 92. Latin America Bio-Therapeutic Glycoproteins Revenue Market Share by Country in 2019
Figure 93. Mexico Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 98. Argentina Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Figure 100. Latin America Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure 101. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Growth Rate 2015-2020 (K MT)
Figure 102. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue Market Share by Country in 2019
Figure 105. Turkey Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 106. Turkey Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 108. Saudi Arabia Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Bio-Therapeutic Glycoproteins Sales Growth Rate (2015-2020) (K MT)
Figure 110. U.A.E Bio-Therapeutic Glycoproteins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Bio-Therapeutic Glycoproteins Market Share by Type in 2019
Figure 112. Middle East and Africa Bio-Therapeutic Glycoproteins Market Share by Application in 2019
Figure 113. North America Bio-Therapeutic Glycoproteins Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. North America Bio-Therapeutic Glycoproteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Bio-Therapeutic Glycoproteins Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Europe Bio-Therapeutic Glycoproteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Bio-Therapeutic Glycoproteins Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Asia Pacific Bio-Therapeutic Glycoproteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Bio-Therapeutic Glycoproteins Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Latin America Bio-Therapeutic Glycoproteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Bio-Therapeutic Glycoproteins Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Middle East and Africa Bio-Therapeutic Glycoproteins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- ループス治療の世界市場（～2026年） Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. According to the report, one of the major drivers for this market is high prevalence rate. Market Analysis and Insights: Global Lupus Therapeutic Market The global Lupus Therapeutic market size …
- アルコール性肝炎治療の世界市場（～2026年） Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually …
- 白血病治療の世界市場（～2026年） Leukemia is a type of cancer which is formed in blood tissues. Leukemia occurs in bone marrow which is a soft tissue. Leukemia develops by the uncontrolled growth of blood cells in the bone marrow. Leukemia is also defined as a cancer of white blood cells. Leukemia therapeutics consists of three ste…